Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look

Although immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape of several malignancies, the role of immunotherapy in biliary tract cancer (BTC) is currently under investigation and ICIs are still looking for their niche in this setting. In this Editorial, we discuss recentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricci, Angela Dalia, Rizzo, Alessandro, Brandi, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
The Evolving Landscape of Systemic Treatment in Biliary Tract Cancer: Is It Time For Revolution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791443/
https://www.ncbi.nlm.nih.gov/pubmed/32806956
http://dx.doi.org/10.1177/1073274820948047
Descripción
Sumario:Although immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape of several malignancies, the role of immunotherapy in biliary tract cancer (BTC) is currently under investigation and ICIs are still looking for their niche in this setting. In this Editorial, we discuss recently published data regarding ICIs in BTC, with a particular focus in terms of selection of patients and biomarker-driven trials.

Ejemplares similares